Current gaps in understanding the molecular basis of FXTAS

Tremor and Other Hyperkinetic Movements

Volumn 2, Issue , 2012, Pages

  Hagerman, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer; Fragile X syndrome; Neurodegeneration; Neurodevelopment; Parkinson; Primary ovarian insufficiency

Indexed keywords

EID: 85113601514     PISSN: None     EISSN: 21608288     Source Type: Journal    
DOI: 10.5334/TOHM.123     Document Type: Article

References (70)

1. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001;57:127-130.
2. Hall DA, Berry-Kravis E, Jacquemont S, et al. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology 2005;65:299-301, http://dx.doi.org/10.1212/01.wnl.0000168900. 86323.9c.
3. Kenneson A, Zhang F, Hagedorn CH, et al. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001; 10:1449-1454, http://dx.doi.org/10.1093/hmg/10.14.1449.
4. Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000;66:6-15, http://dx.doi.org/10.1086/302720.
5. Hagerman PJ, Hagerman RJ. The fragile-X premutation: A maturing perspective. Am J Hum Genet 2004;74:805-816, http://dx.doi.org/10.1086/ 386296.
6. Willemsen R, Levenga J, Oostra B. CGG repeat in the FMR1 gene: Size matters. Clin Genet 2011;80:214-225, http://dx.doi.org/10.1111/j.1399-0004. 2011.01723.x.
7. Hagerman R, Au J, Hagerman P. FMR1 premutation and full mutation molecular mechanisms related to autism. J Neurodev Disord 2011;3:211-224, http://dx.doi.org/10.1007/s11689-011-9084-5.
8. Coffey SM, Cook K, Tartaglia N, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 2008;146A:1009-1016, http://dx.doi.org/10.1002/ajmg.a.32060.
9. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 2009;17:1359-1362, http://dx.doi.org/10.1038/ ejhg.2009.51.
10. Chonchaiya W, Au J, Schneider A, et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 2012;131(4):581-589, http://dx.doi.org/10. 1007/s00439-011-1106-6.
11. Lee JE, Cooper TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009;37:1281-1286, http://dx.doi.org/10.1042/ BST0371281.
12. Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 2007;20:572-576, http://dx.doi.org/10. 1097/WCO.0b013e3282ef6064.
13. Sellier C, Rau F, Liu Y, et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 2010;29:1248-1261, http://dx.doi.org/10.1038/emboj.2010.21.
14. Chawla G, Lin CH, Han A, et al. Sam68 regulates a set of alternatively spliced exons during neurogenesis. Mol Cell Biol 2009;29:201-213, http://dx. doi.org/10.1128/MCB.01349-08.
15. Paronetto MP, Achsel T, Massiello A, et al. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J Cell Biol 2007;176:929-939, http://dx.doi.org/10.1083/jcb.200701005.
16. Jin P, Duan R, Qurashi A, et al. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 2007;55:556-564, http://dx.doi.org/10.1016/ j.neuron.2007.07.020.
17. Qurashi A, Li W, Zhou JY, et al. Nuclear accumulation of stress response mRNAs contributes to the neurodegeneration caused by fragile X premutation rCGG repeats. PLoS Genet 2011;7:e1002102, http://dx.doi.org/10.1371/ journal.pgen.1002102.
18. Khalili K, Del Valle L, Muralidharan V, et al. Pur alpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol 2003;23:6857- 6875, http://dx.doi.org/10.1128/MCB.23.19.6857-6875.2003.
19. Sofola OA, Jin P, Qin Y, et al. RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 2007;55:565-571, http:// dx.doi.org/10.1016/j.neuron.2007.07.021.
20. Muslimov IA, Patel MV, Rose A, et al. Spatial code recognition in neuronal RNA targeting: Role of RNA-hnRNP A2 interactions. J Cell Biol 2011;194:441-457, http://dx.doi.org/10.1083/jcb.201010027.
21. Subramanian M, Rage F, Tabet R, et al. G-quadruplex RNA structure as a signal for neurite mRNA targeting. EMBO Rep 2011;12:697-704, http:// dx.doi.org/10.1038/embor.2011.76.
22. Sellier C, Hagerman P, Willemsen R, et al. DROSHA/DGCR8 sequestration by expanded CGG repeats leads to global micro-RNA processing alteration in FXTAS patients [abstract]. 12th International Fragile X Conference; July 21-25; Detroit, MI 2010.
23. Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 2004;14:2162-2167, http://dx.doi.org/10.1016/j.cub. 2004.11.001.
24. McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011;90:1-18, http://dx.doi.org/10.1097/MD.0b013e3182060469.
25. Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs. Science 2011;331:550-553, http://dx.doi.org/10.1126/ science.1191138.
26. Napoli E, Ross-Inta C, Wong S, et al. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet 2011;20:3079-3092, http://dx.doi.org/10.1093/ hmg/ddr211.
27. Ross-Inta C, Omanska-Klusek A, Wong S, et al. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J 2010;429:545-552, http://dx.doi.org/10.1042/BJ20091960.
28. Garcia-Arocena D, Yang JE, Brouwer JR, et al. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet 2010;19:299-312, http://dx.doi.org/10.1093/hmg/ddp497.
29. Jenkins EC, Tassone F, Ye L, et al. Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. Am J Med Genet A 2008;146A:1543-1546, http://dx.doi.org/10.1002/ajmg.a.32342.
30. Hall DA, Howard K, Hagerman R, et al. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord 2009;15:156-159, http://dx.doi.org/10.1016/j. parkreldis.2008.04.037.
31. Loesch DZ, Godler DE, Evans A, et al. Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genet Med 2011;13:392-399, http://dx.doi.org/10.1097/GIM.0b013e3182064362.
32. Loesch DZ, Khaniani MS, Slater HR, et al. Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism. Clin Genet 2009;76:471-476, http://dx.doi.org/10.1111/j.1399-0004.2009.01275.x.
33. Bourgeois JA, Coffey SM, Rivera SM, et al. A review of fragile X premutation disorders: Expanding the psychiatric perspective. J Clin Psychiatry 2009;70:852-862, http://dx.doi.org/10.4088/JCP.08r04476.
34. Seritan AL, Nguyen DV, Farias ST, et al. Dementia in fragile Xassociated tremor/ataxia syndrome (FXTAS): Comparison with Alzheimer’s disease. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1138-1144, http://dx. doi.org/10.1002/ajmg.b.30732.
35. Chinta SJ, Andersen JK. Nitrosylation and nitration of mitochondrial complex I in Parkinson’s disease. Free Radic Res 2011;45:53-58, http://dx.doi. org/10.3109/10715762.2010.509398.
36. Lin TK, Liou CW, Chen SD, et al. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson’s disease. Chang Gung Med J 2009;32: 589-599.
37. Van Laar VS, Berman SB. Mitochondrial dynamics in Parkinson’s disease. Exp Neurol 2009;218:247-256, http://dx.doi.org/10.1016/j.expneurol. 2009.03.019.
38. Yao Z, Wood NW. Cell death pathways in Parkinson’s disease: Role of mitochondria. Antioxid Redox Signal 2009;11:2135-2149, http://dx.doi.org/10. 1089/ars.2009.2624.
39. Schon EA, Przedborski S. Mitochondria: The next (neurode)generation. Neuron 2011;70:1033-1053, http://dx.doi.org/10.1016/j.neuron.2011.06.003.
40. Cunningham CL, Martı´nez Cerden˜o V, Navarro Porras E, et al. Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Hum Molec Genet 2011;20:64-79, http://dx.doi.org/ 10.1093/hmg/ddq432.
41. Chen Y, Tassone F, Berman RF, et al. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet 2010;19:196-208, http://dx.doi.org/10.1093/ hmg/ddp479.
42. Hunsaker MR, Wenzel HJ, Willemsen R, et al. Progressive spatial processing deficits in a mouse model of the fragile X premutation. Behav Neurosci 2009;123:1315-1324, http://dx.doi.org/10.1037/a0017616.
43. Goodrich-Hunsaker N, Wong L, McLennan Y, et al. Young adult female fragile X premutation carriers show age-and genetically-modulated cognitiveimpairments. Brain Cogn 2011;75:255-260, http://dx.doi.org/10.1016/j.bandc. 2011.01.001.
44. Qin M, Entezam A, Usdin K, et al. A mouse model of the fragile X premutation: Effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis. Neurobiol Dis 2011;42:85-98, http://dx.doi.org/10. 1016/j.nbd.2011.01.008.
45. Hunsaker MR, Arque G, Berman RF, et al. Mouse models of the fragile X premutation and the fragile X associated tremor/ataxia syndrome. Results Probl Cell Differ 2012;54:255-269, http://dx.doi.org/10.1007/978-3-642- 21649-7_14.
46. Brouwer JR, Huizer K, Severijnen LA, et al. CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile Xassociated tremor/ataxia syndrome. J Neurochem 2008;107:1671-1682, http:// dx.doi.org/10.1111/j.1471-4159.2008.05747.x.
47. Tassone F, Hagerman RJ, Taylor AK, et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 2000; 91: 144-152, ht t p://dx. doi.org/10. 1 002/(SICI)10 96- 8628(20000313)91:2,144::AID-AJMG14.3.0.CO;2-V.
48. Goodlin-Jones BL, Tassone F, Gane LW, et al. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr 2004;25:392-398, http://dx.doi.org/10.1097/00004703-200412000-00002.
49. Hessl D, Wang JM, Schneider A, et al. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biol Psychiatry 2011;70:859-865, http://dx.doi.org/10. 1016/j.biopsych.2011.05.033.
50. Aziz M, Stathopulu E, Callias M, et al. Clinical features of boys with fragile X premutations and intermediate alleles. Am J Med Genet B Neuropsychiatr Genet 2003;121:119-127, http://dx.doi.org/10.1002/ajmg.b.20030.
51. Farzin F, Perry H, Hessl D, et al. Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation. J Dev Behav Pediatr 2006;27:S137-S144, http://dx.doi.org/10. 1097/00004703-200604002-00012.
52. Hagerman R, Hoem G, Hagerman P. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Molec Autism 2010;1:12, http://dx.doi.org/10.1186/2040-2392-1-12.
53. Leehey M, Hagerman P. Fragile X-associated tremor/ataxia syndrome. In: Vinken P, Bruyn G, editors. Handbook of Clinical Neurology. New York: Wiley Interscience Division;2012:373-386.
54. Roberts J, Mazzocco MM, Murphy MM, et al. Arousal modulation in females with fragile X or Turner syndrome. J Autism Dev Disord 2008;38:20-27, http://dx.doi.org/10.1007/s10803-007-0356-6.
55. Hamlin A, Liu Y, Nguyen D, et al. Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet Part B: Neuropsychiatric Genetics 2011;156:23-928.
56. Bodega B, Bione S, Dalpra L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21:952-957, http://dx.doi.org/10.1093/ humrep/dei432.
57. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-382, http://dx.doi.org/10.1007/s00439-005- 1326-8.
58. Hall D, Pickler L, Riley K, et al. Parkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord 2010;25:1523-1524, http://dx.doi.org/10. 1002/mds.23150.
59. Hunsaker MR, Greco CM, Tassone F, et al. Rare intranuclear inclusions in the brains of 3 older adult males with fragile X syndrome: Implications for the spectrum of fragile X-associated disorders. J Neuropathol Exp Neurol 2011;70: 462-469, http://dx.doi.org/10.1097/NEN.0b013e31821d3194.
60. Utari A, Adams E, Berry-Kravis E, et al. Aging in fragile X syndrome. J Neurodev Disord 2010;2:70-76, http://dx.doi.org/10.1007/s11689-010-9047-2.
61. Luo Y, Shan G, Guo W, et al. Fragile X mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet 2010;6:e1000898, http://dx.doi.org/10.1371/journal.pgen. 1000898.
62. Hall DA, Berry-Kravis E, Zhang W, et al. FMR1 gray-zone alleles: Association with Parkinson’s disease in women? Mov Disord 2011;26:1900-1906, http://dx.doi.org/10.1002/mds.23755.
63. Loesch DZ, Bui QM, Huggins RM, et al. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet 2007;44:200-204, http://dx.doi.org/10.1136/jmg.2006.043950.
64. Cilia R, Kraff J, Canesi M, et al. Screening for the presence of FMR1 premutation alleles in women with parkinsonism. Arch Neurol 2009;66:244-249, http://dx.doi.org/10.1001/archneurol.2008.548.
65. Deng H, Le W, Jankovic J. Premutation alleles associated with Parkinson disease and essential tremor. JAMA 2004;292:1685-1686, http://dx.doi.org/ 10.1001/jama.292.14.1685-b.
66. Kraff J, Tang HT, Cilia R, et al. Screen for excess FMR1 premutation alleles among males with parkinsonism. Arch Neurol 2007;64:1002-1006, http:// dx.doi.org/10.1001/archneur.64.7.1002.
67. Kurz MW, Schlitter AM, Klenk Y, et al. FMR1 alleles in Parkinson’s disease: Relation to cognitive decline and hallucinations, a longitudinal study. J Geriatr Psychiatry Neurol 2007;20:89-92, http://dx.doi.org/10.1177/ 0891988706297737.
68. Reis AH, Ferreira AC, Gomes KB, et al. Frequency of FMR1 premutation in individuals with ataxia and/or tremor and/or parkinsonism. Genet Mol Res 2008;7:74-84, http://dx.doi.org/10.4238/vol7-1gmr357.
69. Tan EK, Zhao Y, Puong KY, et al. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 2004;63:362-363.
70. Toft M, Aasly J, Bisceglio G, et al. Parkinsonism, FXTAS, and FMR1 premutations. Mov Disord 2005;20:230-233, http://dx.doi.org/10.1002/mds. 20297.